J Thorac Cardiovasc Surg 2008;135:1252-1253
© 2008 The American Association for Thoracic Surgery
Discussion
| The first 20% of the full text of this article appears below. |
Dr Michael Acker
(Philadelphia, Pa). I congratulate the authors for this well-conducted study using what is considered by many as the gold standard in looking at cardiac volumes. You confirmed in your patients with moderate heart failure that by correcting MR we can see reverse remodeling, which we have seen in many other types of groups. I have 4 questions.
Mitral insufficiency and heart failure are often very dynamic, and these patients were not that sick. Were these patients really optimized on standard advanced medical therapy before you attempted to operate? How long were they followed before making the decision to operate?
Dr Jerry Braun
(Leiden, The Netherlands). All patients were on a good medical treatment strategy. All patients had at least had diuretics.
Dr Acker. Were they all on beta-blockers and angiotensin-converting enzyme inhibitors? If not, what percentage?
Dr Braun. All patients were receiving angiotensin-converting enzyme inhibitors, and . . . [Full Text of this Article]
Related Article
-
Magnetic resonance imaging assessment of reverse left ventricular remodeling late after restrictive mitral annuloplasty in early stages of dilated cardiomyopathy
- Jos J.M. Westenberg, Jerry Braun, Nico R. Van de Veire, Robert J.M. Klautz, Michel I.M. Versteegh, Stijntje D. Roes, Rob J. van der Geest, Albert de Roos, Ernst E. van der Wall, Johan H.C. Reiber, Jeroen J. Bax, and Robert A.E. Dion
J. Thorac. Cardiovasc. Surg. 2008 135: 1247-1253.
[Abstract]
[Full Text]
[PDF]
Copyright © 2008 by The American Association for Thoracic Surgery.